Webinar Date/Time: Tuesday, January 9, 2024 at 11am EST | 8am PST | 4pm GMT| 5pm CET
In this webinar, the presenters will explore how complex materials can be efficiently and confidently verified using non-invasive spatially offset Raman spectroscopy (SORS). Polysorbates, solvents, and stearates will be used as case studies to demonstrate how SORS reduces risk, improves efficiency, and simplifies compliance and quality.
Register Free:
https://www.spectroscopyonline.com/spec_w/RMID
Event Overview:
While conventional handheld Raman instruments have improved raw material verification processes for many pharmaceutical drug manufacturing facilities, complex raw materials still pose significant challenges. Common complex materials—like polysorbates, solvents, and stearates—often require time-consuming and quality-compromising sampling procedures due to their remarkable spectral similarity and the challenging containers in which they’re received. Especially when received at high volumes, this prevents efficient raw material verification and can often cause bottlenecks in release to production and waste, as well as risk to raw material quality.
In this webinar, the presenters will explore how complex materials can be efficiently and confidently verified using non-invasive spatially offset Raman spectroscopy (SORS). Three common, high-volume, and complex materials (polysorbates, solvents, and stearates) will be used as case studies to demonstrate how SORS reduces risk, improves efficiency, and simplifies compliance and quality.
Key Learning Objectives:
Who Should Attend:
Speakers:
Soleil Grise
Product Manager, Handheld Raman ID Solutions
Agilent Technologies
Soleil Grise is Product Manager for Handheld Raman Identification products at Agilent Technologies. Soleil leads the product development and commercialization of spatially offset Raman spectroscopy-based solutions, particularly for verifying raw materials at reception. She joined Agilent Technologies in 2022 and has a background in scientific instruments designed for biopharmaceutical development.
Chris Welsby
Applications Development Engineer
Agilent Technologies
Chris Welsby is an Applications Development Engineer supporting the Handheld Raman Identification Products and also the company’s Transmission Raman product for content uniformity measurement. He has quite a varied remit, including collaboration with R&D to investigate potential hardware and software enhancements, developing applications and composing application notes, providing technical support to customers, and assisting with pre-sales evaluation. Chris joined Cobalt Light Systems at the start of 2016 and transferred to Agilent Technologies when Agilent acquired Cobalt in late 2017.
Register Free: https://www.spectroscopyonline.com/spec_w/RMID
AI-Powered Spectroscopy Faces Hurdles in Rapid Food Analysis
September 4th 2024A recent study reveals on the challenges and limitations of AI-driven spectroscopy methods for rapid food analysis. Despite the promise of these technologies, issues like small sample sizes, misuse of advanced modeling techniques, and validation problems hinder their effectiveness. The authors suggest guidelines for improving accuracy and reliability in both research and industrial settings.
Nanometer-Scale Studies Using Tip Enhanced Raman Spectroscopy
February 8th 2013Volker Deckert, the winner of the 2013 Charles Mann Award, is advancing the use of tip enhanced Raman spectroscopy (TERS) to push the lateral resolution of vibrational spectroscopy well below the Abbe limit, to achieve single-molecule sensitivity. Because the tip can be moved with sub-nanometer precision, structural information with unmatched spatial resolution can be achieved without the need of specific labels.
Real-Time Monitoring of Spike Protein Purification Using Raman and NIR Spectroscopy
August 26th 2024Researchers at Budapest University of Technology and Economics have developed a novel method for real-time monitoring of the protein purification process using Raman and near-infrared (NIR) spectroscopy. Their study compares the effectiveness of these two spectroscopic techniques in tracking the removal of imidazole, a process-related impurity, during the purification of the SARS-CoV-2 spike protein's receptor-binding domain (RBD).